Henrik Clausen, DDS, DSc.
Dr. Clausen is professor, Faculty of Health Sciences, Department of Medical Biochemistry and Genetics, University of Copenhagen. He is an expert in the field of gene cloning and host cell expression of mammalian glycosyltransferases.

Richard D. Cummings, Ph.D.
Dr. Cummings is the William Patterson Timmie Professor and Chair of the Department of Biochemistry, Emory University School of Medicine. In addition, Dr. Cummings is Director of the Oklahoma Center for Medical Glycobiology. He is a recognized leader in the field of glycobiology with more than 150 scientific publications and review and 17 issued patents. Dr. Cummings’ research focuses on the functions and biosynthesis of glycoconjugates, including carbohydrate-binding proteins (selectins and galectins) and glycosyltransferases.

David James, Ph.D.
Dr. James is a Professor of Bioprocess Engineering, School of Engineering, University of Queensland. He has made important discoveries relating minor structural changes in the carbohydrate chains of monoclonal antibodies to major changes in the ability of the antibodies to turn on immune effector function.

James C. Paulson, Ph.D.
Dr. Paulsen is the Director of the Consortium for Functional Glycomics, which is funded by a $34 million NIGMS glue grant. He is a world renowned glycobiologist and the inventor on several key patents licensed to Neose that relate to core, enabling technologies for GlycoAdvance. Dr. Paulson was formerly vice president of research and chief scientific officer of Cytel Corporation prior to Neose's acquisition of Cytel's carbohydrate synthesis technology in 1999.

 

©2002 Neose Technologies, Inc. All Rights Reserved
Print right half of page content